|
Product class:
|
Medicinal product with marketing authorization
|
|
Medicinal product class:
|
Veterinary medicine
|
|
Name of medicinal product:
|
Depo-Medrone V
|
|
Active substances:
|
|
|
ATC code:
|
QH02AB04
|
|
Dosage form:
|
suspension for injection
|
|
Strength:
|
40mg 1ml
|
|
Legal status for supply*:
|
Subject to medicinal prescription
|
|
Summary of product characteristics (SPC):
|
 (last updated May 29, 2020)
|
|
Package information leaflet (PIL):
|
EST (last updated September 4, 2023)
|
|
Labelling:
|
(last updated May 29, 2020)
|
|
Indication:
|
|
|
Marketing authorization holder:
|
Zoetis Belgium
|
|
Marketing authorization number:
|
1400
|
|
Marketing authorization issued on:
|
June 2, 2000
|
|
Marketing authorization expires on:
|
Unlimited
|
|
Marketing authorization procedure type:
|
National
|
|
Assessment report:
|
|
|
Package code
|
Name of medicinal product
|
Dosage form
|
Package
|
Legal status
|
Reimbursements
|
Reference price
|
Last imported
|
PƤritolumaa
|
Additional information
|
|
1093766
|
Depo-Medrone V
|
suspension for injection
|
40mg 1ml 5ml 1TK
|
Prescription
|
|
|
28.12.2022
|
|
|
Legal status for supply – medicinal product on medical prescription or not subject to medical prescription
You can download Acrobat Reader fromhere